AstraZeneca
Hockessin, DE, United States
Sandra Sze-jung Wu, PhD started her position as a Director of Payer Evidence in AstraZeneca since September 2020. Dr. Wu has brought in 20 years of real-world experience in the evaluation of therapies, disease management programs, and clinical decision support tools for hospitalists, payers, large employer groups and biopharma companies from her prior industry experience in HealthCore, a research subsidiary of Anthem, Inc, and during her tenure in the Center of Evidence-based Practice in the Indianapolis VA Medical Center. She is the lead-author and co-author of journals such as Rheumatology and Therapy, American Health & Drug Benefits, Health Affairs, Managed Care, Applied Clinical Informatics, and Handbook of Healthcare Delivery Systems. She had served as a reviewer for journals such as JAMA, Applied Health Economics and Health Policy, and Inquires. She worked in advanced analytics and predictive modeling for two years as a senior risk analyst for JPMorgan Chase. She received her MS. and Ph.D. in industrial engineering with concentration on healthcare management from the Purdue University.
Disclosure information not submitted.
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
Monday, November 14, 2022
1:00 PM – 3:00 PM Eastern Time
